In MBC_exo, MLRhigh and PLRhigh patients with HER2 BC had a significant higher fraction of CD49dpos exosomes (P = 0.0086, P = 0.0166 respectively) and a trend for CXCR4pos. This evidence concerns the gene ERBB2 and breast cancer.